Skip to content

ADXN

Addex Therapeutics Ltd.

NASDAQ · Healthcare · Biotechnology · CH

$3.07
+6.15%
Ask drillr

Forward multiples

Based on analyst estimates

P/E forward
—
P/E 2026E
—
P/E 2027E
—
P/E 2028E
—
P/S forward
—

Trailing multiples

Trailing twelve months

P/E TTM
—
PEG TTM
—
Price / book
2.31x
Price / sales
92.77x
Price / cash flow
-1.86x

Enterprise value

Enterprise value
$4.5M
EV / sales
78.27x
EV / EBITDA
-0.65x
EV / EBIT
-1.43x
Market cap
$5.4M

Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026